Business Wire Feed
Bruno Vision Care Wins 2026 MedTech Breakthrough Award
Landmark 10th Annual Awards Program Recognizes the Deseyne® Extended Depth of Focus (EDOF) contact lens as the “Best New Technology Solution - Ophthalmology” WorldwideBOCA RATON, Fla.--(BUSINESS WIRE)--#ContactLenses--The Cataltheia Group and its U.S. subsidiary, Bruno Vision more...
WHOOP Expands Health Platform with On-Demand Clinician Access and New AI Features
New updates introduce a more personalized, data-driven member experience—bridging the gap between continuous biometrics, real-world context, and clinical insightBOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today announced a new suite of health and AI-driven enhancements and more...
Bio-Rad to Participate in Upcoming Investor Conferences
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: 2026 RBC more...
Niagen Bioscience Announces Participation in Upcoming Investor Conferences
LOS ANGELES--(BUSINESS WIRE)--$NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior leadership will participate in the following more...
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to delay the launch of the previously announced tender more...
Kanvas Biosciences Receives New Funding to Develop First-In-Category Microbiome Therapeutic for Improving Maternal, Newborn and Child Health
The oral product, funded by Gates Foundation, will treat and prevent environmental enteric dysfunction (EED) in pregnant persons across Southern Asia and Sub-Saharan Africa.PRINCETON, N.J.--(BUSINESS WIRE)--Kanvas Biosciences, a full-stack spatial biology and microbial therapeutics company, more...
Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
Topline results for the randomized portion of PALISADE-4 are expected in the second quarter of 2026SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and more...
On World Ovarian Cancer Day, LGSOC Resource Guide Launches to Support People Living with Low-Grade Serous Ovarian Cancer
Available at LGSOCAwarenessDay.Org, the LGSOC Resource Guide brings together resources from patient advocacy groups, covering topics from diagnosis to survivorshipBOSTON--(BUSINESS WIRE)--Today, STAAR Low-Grade Serous Ovarian Cancer Foundation, Not These Ovaries, and Verastem Oncology announced the more...
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans to participate in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas, more...
Herbalife and Cristiano Ronaldo Bring Performance Nutrition to Everyday Routines with “Fuel Like Ronaldo” Campaign
Backed by more than 20 years of experience fueling elite athletes, Herbalife brings its proven performance nutrition expertise to wellness seekers worldwideLOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and more...
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in quality of life as reflected in more...
Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities Health Care Conference. Executive Vice President, Corporate Strategy & CEO Designate Daniel Bendheim; Chief Operating Officer, more...
Elite Learning Celebrates Nurses Month with The Real Nurse Nation Virtual Tour
Each Virtual Tour Stop Includes Resources and Giveaways Throughout the Month Dedicated to the Nurses Who Keep the Show GoingORMAND BEACH, Fla.--(BUSINESS WIRE)--Elite Learning, a comprehensive online learning destination for licensed professionals, today announced the more...
LTC to Participate in the BMO North American Real Estate Conference
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--$LTC #LTC--LTC Properties Inc. (NYSE: LTC) (“LTC” or the “Company”), announced today senior management will participate in the BMO North American Real Estate Conference on May 12, 2026 in New York. The more...
BetterHelp Launches “Motherhood With You” Series and Month-Long Giveback Committing Over 100,000 Hours of Therapy to Mothers
Featuring partnerships with three WNBA teams, Baby2Baby, March of Dimes, and prominent voices across sports and entertainment supporting mothers nationwideSAN JOSE, Calif.--(BUSINESS WIRE)--This Mother’s Day, BetterHelp, the world's largest online therapy platform, is launching Motherhood more...
Evommune Reports First Quarter 2026 Financial Results and Provides Business Highlights
‑ Phase 2b top-line data from EVO756 in chronic spontaneous urticaria (CSU) and atopic dermatitis (AD) on track for June 2026 and 3Q26, respectively, with enrollment complete in both trials ‑ Phase 2b clinical trial more...
Prothena Reports First Quarter 2026 Financial Results and Business Highlights
Net cash provided by operating and investing activities was $28.9 million for the first quarter of 2026; quarter-end cash and restricted cash position was $330.3 million Prothena updates projected full year 2026 net cash used more...
Once Upon a Farm Reports First Quarter 2026 Financial Results
First quarter net sales increased 44% year-over-year to $73 million Raising 2026 net sales outlook to $313 million to $323 millionBERKELEY, Calif.--(BUSINESS WIRE)--Once Upon a Farm, PBC (NYSE: OFRM) (or the “Company”), a leading high-growth more...
AbCellera to Present at Upcoming Investor Conferences in May and June 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences: Bank of America Health Care Conference, May 13, 2026 Jefferies Global Healthcare Conference in New York, June more...
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May
- Presentations to be webcast on www.exelixis.com -ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in May: BofA Securities Health Care Conference more...
FIGS and Noah Wyle Launch Long-Term Partnership to Advocate for the Healthcare Workforce and Reduce Medical Debt
Wyle’s role as FIGS Brand Ambassador to kick off at FIGS’ Healthcare is Human Rally outside the U.S. Capitol on May 21, 2026SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand, more...
AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will participate in more...
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
Pivotal Phase 2 trial of RP-A501 for Danon disease progressing with dosing reinitiated First patient dosing in Phase 1 study of RP-A701 for BAG3-related dilated cardiomyopathy anticipated in mid-2026 KRESLADI™ granted FDA accelerated approval; Rare more...
Aptar Pharma Announces Progress on Multi-Year U.S. FDA-Funded Research Contract
Contract is Focused on Advancing Transition of Metered‑Dose Inhalers Toward Next-Generation PropellantsCRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced continued progress on its awarded research more...
Reprieve Cardiovascular Announces Publication of FASTR Pilot Trial Results in JACC: Heart Failure
-- Peer-reviewed publication reports faster decongestion with Reprieve Therapy and no increased risk of safety events or worsening kidney function compared to optimal diuretic therapy --MILFORD, Mass.--(BUSINESS WIRE)--Reprieve Cardiovascular, Inc., a development-stage company focused on more...